Discontinued — last reported Q3 '16
Other
Remainder of Fiscal Year 2025
Amgen Remainder of Fiscal Year 2025 decreased by 55.0% to $900.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from $1.20B to $900.00M.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ3 2016
Last reportedQ3 2016
Metric ID:
remainder_2025Historical Data
14 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20B | $600.00M | $1.90B | $1.30B | $600.00M | $2.10B | $1.40B | $700.00M | $3.60B | $2.40B | $1.20B | $3.10B | $2.00B | $900.00M |
| QoQ Change | — | -50.0% | +216.7% | -31.6% | -53.8% | +250.0% | -33.3% | -50.0% | +414.3% | -33.3% | -50.0% | +158.3% | -35.5% | -55.0% |
| YoY Change | — | — | — | +8.3% | +0.0% | +10.5% | +7.7% | +16.7% | +71.4% | +71.4% | +71.4% | -13.9% | -16.7% | -25.0% |
Range$600.00M – $3.60B
CAGR-8.5%
Avg YoY Growth+18.4%
Median YoY Growth+8.3%
Current Streak2 quarters decline
Remainder of Fiscal Year 2025 at Other Companies
Frequently Asked Questions
- What is Amgen's remainder of fiscal year 2025?
- Amgen (AMGN) reported remainder of fiscal year 2025 of $900.00M in Q3 2025.
- How has Amgen's remainder of fiscal year 2025 changed year-over-year?
- Amgen's remainder of fiscal year 2025 decreased by 25.0% year-over-year, from $1.20B to $900.00M.